loading

You are welcome to send your RFP, feasibility questionnaire or other request at info@mt.clinic

    «BioEq» recruits for patients with non-small cells lung cancer to participate in a phase II clinical study.

    Study medication: monoclonal anti-PD-1 antibody.

    We invite adult male and female patients with: 

    • Histological verificate nonresectable or metastatic non-small cells lung cancer
    • Radiological approved disease progression after chemotherapy against platinum-based drugs
    • Deficit of mutation EGFR or ALK
    • Deficit of progressing secondary tumor in axion (central nervous system)

    Please contact us at 8-812-945-22-32 to learn more.

    1 Comment

    1. admin

      Informe a su proveedor de atención médica de inmediato si tiene algún efecto secundario que le moleste o no desaparezca.

    Write a Reply or Comment

    Your email address will not be published. Required fields are marked *